These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 28431829)

  • 21. Prodromal Parkinson's disease as defined per MDS research criteria in the general elderly community.
    Mahlknecht P; Gasperi A; Willeit P; Kiechl S; Stockner H; Willeit J; Rungger G; Sawires M; Nocker M; Rastner V; Mair KJ; Hotter A; Poewe W; Seppi K
    Mov Disord; 2016 Sep; 31(9):1405-8. PubMed ID: 27273736
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Performance of the Movement Disorders Society criteria for prodromal Parkinson's disease: A population-based 10-year study.
    Mahlknecht P; Gasperi A; Djamshidian A; Kiechl S; Stockner H; Willeit P; Willeit J; Rungger G; Poewe W; Seppi K
    Mov Disord; 2018 Mar; 33(3):405-413. PubMed ID: 29436728
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Association between olfactory loss and cognitive deficits in Parkinson's disease.
    Camargo CHF; Jobbins VA; Serpa RA; Berbetz FA; Sabatini JS; Teive HAG
    Clin Neurol Neurosurg; 2018 Oct; 173():120-123. PubMed ID: 30121454
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinical, neuropsychological and epidemiological aspects of the 'transitional' form of Parkinson's disease in the Yaroslavl region].
    Pizova NV; Bykanova MA; Kurapin EV
    Zh Nevrol Psikhiatr Im S S Korsakova; 2019; 119(4):66-71. PubMed ID: 31156225
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Contribution of auditory P300 test to the diagnosis of mild cognitive impairment in Parkinson's disease.
    Yilmaz FT; Özkaynak SS; Barçin E
    Neurol Sci; 2017 Dec; 38(12):2103-2109. PubMed ID: 28887694
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnosing mild cognitive impairment in Parkinson's disease: which tests perform best in the Italian population?
    Federico A; Trentin M; Zanette G; Mapelli D; Picelli A; Smania N; Tinazzi M; Tamburin S
    Neurol Sci; 2017 Aug; 38(8):1461-1468. PubMed ID: 28550344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk and incidence of dementia in a cohort of older subjects with Parkinson's disease in the United Kingdom.
    Hobson P; Meara J
    Mov Disord; 2004 Sep; 19(9):1043-9. PubMed ID: 15372593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The characteristics and treatment patterns of patients with Parkinson's disease in the United States and United Kingdom: A retrospective cohort study.
    Kalilani L; Friesen D; Boudiaf N; Asgharnejad M
    PLoS One; 2019; 14(11):e0225723. PubMed ID: 31756215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Diagnosis of possible mild cognitive impairment in Parkinson's disease: validity of the SCOPA-Cog.
    Isella V; Mapelli C; Morielli N; Siri C; De Gaspari D; Pezzoli G; Antonini A; Poletti M; Bonuccelli U; Picchi L; Napolitano A; Vista M; Appollonio IM
    Parkinsonism Relat Disord; 2013 Dec; 19(12):1160-3. PubMed ID: 24011719
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinicoradiological comparison between vascular parkinsonism and Parkinson's disease.
    Vale TC; Caramelli P; Cardoso F
    J Neurol Neurosurg Psychiatry; 2015 May; 86(5):547-53. PubMed ID: 25006209
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Parkinson's disease dementia: Diagnostic criteria and risk factor review.
    Vasconcellos LF; Pereira JS
    J Clin Exp Neuropsychol; 2015; 37(9):988-93. PubMed ID: 26332178
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Parkinson's disease mild cognitive impairment classifications and neurobehavioral symptoms.
    McDermott KL; Fisher N; Bradford S; Camicioli R
    Int Psychogeriatr; 2018 Feb; 30(2):253-260. PubMed ID: 29094664
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Risk of Parkinson's disease dementia related to level I MDS PD-MCI.
    Hoogland J; Boel JA; de Bie RMA; Schmand BA; Geskus RB; Dalrymple-Alford JC; Marras C; Adler CH; Weintraub D; Junque C; Pedersen KF; Mollenhauer B; Goldman JG; Tröster AI; Burn DJ; Litvan I; Geurtsen GJ;
    Mov Disord; 2019 Mar; 34(3):430-435. PubMed ID: 30653248
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Correlation between the Movement Disorders Society Unified Parkinson's Disease rating scale (MDS-UPDRS) and the Unified Parkinson's Disease rating scale (UPDRS) during L-dopa acute challenge.
    Merello M; Gerschcovich ER; Ballesteros D; Cerquetti D
    Parkinsonism Relat Disord; 2011 Nov; 17(9):705-7. PubMed ID: 21784692
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of integrity and atrophy in cingulate structural covariance networks in Parkinson's disease.
    de Schipper LJ; van der Grond J; Marinus J; Henselmans JML; van Hilten JJ
    Neuroimage Clin; 2017; 15():587-593. PubMed ID: 28652971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Differentiating vascular parkinsonism from idiopathic Parkinson's disease: a systematic review.
    Kalra S; Grosset DG; Benamer HT
    Mov Disord; 2010 Jan; 25(2):149-56. PubMed ID: 20077476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Importance of Balance-Gait Disorder as a Risk Factor for Cognitive Impairment, Dementia and Related Non-Motor Symptoms in Parkinson's Disease.
    Lichter DG; Benedict RHB; Hershey LA
    J Parkinsons Dis; 2018; 8(4):539-552. PubMed ID: 30124451
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of levodopa on frontal-subcortical and posterior cortical functioning in patients with Parkinson's disease.
    Gul A; Yousaf J
    Singapore Med J; 2019 Aug; 60(8):414-417. PubMed ID: 30246215
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cognitive impairment in early-stage non-demented Parkinson's disease patients.
    Pfeiffer HC; Løkkegaard A; Zoetmulder M; Friberg L; Werdelin L
    Acta Neurol Scand; 2014 May; 129(5):307-18. PubMed ID: 24117192
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa).
    Mollenhauer B; Zimmermann J; Sixel-Döring F; Focke NK; Wicke T; Ebentheuer J; Schaumburg M; Lang E; Friede T; Trenkwalder C;
    Mov Disord; 2019 Jan; 34(1):67-77. PubMed ID: 30468694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.